Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | FDPS | P14324 | 1/20 | 0.35 |
| ▸ | HMGCR | P04035 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | PGK1 | P00558 | 1/20 | 0.33 |
| ▸ | PGK2 | P07205 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2372647 | 0.82 | LMNA (0.50) | TSHRALDH1A1LMNAFDPSHMGCR | |
| Pivalate SCHEMBL26125376 | 0.71 | TSHR (0.47) | TSHRALDH1A1LMNAFDPSHMGCR | |
| Phosphoric Acid SCHEMBL28561793 | 0.70 | LMNA (0.56) | TSHRALDH1A1LMNATHRBFDPS | |
| Phosphoric Acid SCHEMBL21225977 | 0.69 | TSHR (0.44) | TSHRALDH1A1LMNAFDPSHMGCR | |
| Methyl Phosphonate SCHEMBL28791222 | 0.67 | CA2 (0.61) | TSHRALDH1A1LMNATHRBFDPS | |
| SCHEMBL8015421 | 0.67 | LMNA (0.53) | TSHRALDH1A1LMNATHRBFDPS | |
| SCHEMBL722965 | 0.67 | LMNA (0.46) | TSHRALDH1A1LMNAFDPSHMGCR | |
| SCHEMBL8838818 | 0.67 | LMNA (0.45) | TSHRALDH1A1LMNAFDPSPGK1 | |
| SCHEMBL1336319 | 0.67 | LMNA (0.45) | TSHRALDH1A1LMNAFDPSPGK1 | |
| SCHEMBL7654249 | 0.67 | LMNA (0.45) | TSHRALDH1A1LMNAFDPSPGK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1892 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119775741-B | Tough high-barrier functional film material and preparation method and application thereof | 江南大学 | 2026-05-19 | — | — | CN | claimed |
| CN-122055142-A | Improved pill design for administration to ruminants and uses thereof | 反刍动物生物科技有限公司 | 2026-05-15 | — | — | CN | claimed |
| CN-122037488-A | Biodegradable composition and preparation method and application thereof | 珠海金发生物材料有限公司 | 2026-05-15 | — | — | CN | claimed |
| CN-122025786-A | Three-dimensional composite crystal polymer electrolyte, preparation method thereof and lithium metal battery | 深圳大学 | 2026-05-12 | — | — | CN | claimed |
| CN-122011700-A | Biodegradable composition and preparation method and application thereof | 珠海金发生物材料有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-20260102265-A1 | POLYMER STENT FOR BELOW THE KNEE TREATMENT OF PERIPHERAL ARTERY DISEASE | ABBOTT CARDIOVASCULAR SYSTEMS INC (US) | 2026-04-16 | — | — | US | claimed |
| EP-4107215-B1 | METHODS AND SYSTEMS FOR LACTIC ACID PRODUCTION AND POLYLACTIC ACID RECYCLING | TRIPLEW LTD (IL) | 2026-04-15 | — | — | EP | claimed |
| EP-3426312-B1 | SURFACE TREATED BIOCOMPOSITE MATERIAL, MEDICAL IMPLANTS COMPRISING SAME AND METHODS OF TREATMENT THEREOF | OSSIO LTD (IL) | 2026-03-25 | — | — | EP | claimed |
| EP-3872134-B1 | POLYMER COMPOSITION COMPRISING PLLA AND PDLA | BIO TEC BIOLOGISCHE NATURVERPACKUNGEN GMBH & CO KG (DE) | 2026-01-28 | — | — | EP | claimed |
| EP-4458706-B1 | THERMOFORMING OF PLA-BASED ARTICLES | PURAC BIOCHEM BV (NL) | 2025-11-12 | — | — | EP | claimed |
| CN-110358271-B | Easily degradable PE wire rod for 3D printing and preparation method and application thereof | 昆明学院 | 2022-03-18 | — | — | CN | claimed |
| US-20220082248-A1 | CONTAINER FOR CANDLE PRODUCT | Mueller Fabryka Swiec S.A. (PL) | 2022-03-17 | — | — | US | claimed |
| CN-114181506-A | Preparation method and application of toughened ultrahigh-fluidity polylactic acid | 中广核俊尔(浙江)新材料有限公司 | 2022-03-15 | — | — | CN | claimed |
| US-20220072139-A1 | STEREOCOMPLEXES FOR THE DELIVERY OF ANTI-CANCER AGENTS | TIEN DER YANG (US) | 2022-03-10 | — | — | US | claimed |
| CN-114103274-A | Biodegradable toughened high-temperature-resistant composite straw | 杭州同杰诚新材料有限公司 | 2022-03-01 | — | — | CN | claimed |
| CN-114106532-A | Flame-retardant high-toughness PLA alloy material and preparation method and application thereof | 金发科技股份有限公司 | 2022-03-01 | — | — | CN | claimed |
| WO-2022036234-A1 | SUBCUTANEOUS OR INTRAMUSCULAR INJECTION FORMULATIONS OF ILOPROST | EICOS SCIENCES, INC. (US) | 2022-02-17 | — | — | WO | claimed |
| EP-3195811-B1 | FIXING DEVICE FOR SOFT TISSUE | TRANSEASY MEDICAL TECH CO LTD (CN) | 2018-11-14 | — | — | EP | claimed |
| EP-3195811-A1 | FIXING DEVICE FOR SOFT TISSUE | TransEasy Medical Tech. Co., Ltd. (CN) | 2017-07-26 | — | — | EP | claimed |
| US-20160242766-A1 | Fixing device for soft tissue | TransEasy Medical Tech.Co.,Ltd | 2016-08-25 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260102265-A1 | POLYMER STENT FOR BELOW THE KNEE TREATMENT OF PERIPHERAL ARTERY DISEASE | DUSP23, CLK3, FLT4 | TSHR 2771/4885ALDH1A1 4098/4885LMNA 1624/4885 |
| US-20220072139-A1 | STEREOCOMPLEXES FOR THE DELIVERY OF ANTI-CANCER AGENTS | TOP2A, TSG101, TOP1 | TSHR 4618/4885ALDH1A1 2539/4885LMNA 2051/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.